The company granted stock options to purchase an aggregate of 208,350 shares of Nurix common stock and restricted stock unit awards (RSUs) representing an aggregate of 272,850 shares of Nurix common ...

Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) is expected to announce its earnings results on Thursday, February 20th.

Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) have been assigned a consensus recommendation of “Moderate ...

Piper Sandler analyst Joseph Catanzaro maintained a Buy rating on Gilead Sciences (GILD – Research Report) today and set a price target of ...

Highlights,Sumitomo Mitsui Trust Group Inc. increased its holdings in Nurix Therapeutics by 42.7% in Q4.,Various firms have ...

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies ...

This is the second partnership involving drugs combining ADC and protein degrader technologies in the last few weeks, coming after Seagen formed a wide-ranging partnership with Nurix with a top ...

Eran Ovadya, Chief Financial Officer of NurExone stated, "The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

After hours: February 7 at 6:37:11 PM EST Loading Chart for BCYC ...